Goldman Sachs’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-4,000
| Closed | -$1.4M | – | 6621 |
|
|
2025
Q4 | $1.4M | Sell |
4,000
-4,000
| -50% | -$1.35M | ﹤0.01% | 4879 |
|
|
2025
Q3 | $2.58M | Sell |
8,000
-6,300
| -44% | -$1.96M | ﹤0.01% | 4263 |
|
|
2025
Q2 | $5.56M | Sell |
14,300
-2,100
| -13% | -$845K | ﹤0.01% | 3312 |
|
|
2025
Q1 | $7.13M | Sell |
16,400
-19,500
| -54% | -$7.83M | ﹤0.01% | 3010 |
|
|
2024
Q4 | $13.2M | Sell |
35,900
-15,700
| -30% | -$6.57M | ﹤0.01% | 2531 |
|
|
2024
Q3 | $26.8M | Buy |
51,600
+4,900
| +10% | +$2.62M | ﹤0.01% | 1791 |
|
|
2024
Q2 | $25.3M | Sell |
46,700
-29,200
| -38% | -$15.4M | ﹤0.01% | 1695 |
|
|
2024
Q1 | $39.4M | Buy |
75,900
+10,500
| +16% | +$5.22M | 0.01% | 1318 |
|
|
2023
Q4 | $30.8M | Buy |
65,400
+13,900
| +27% | +$6.43M | 0.01% | 1532 |
|
|
2023
Q3 | $22.4M | Buy |
+51,500
| New | +$23.4M | ﹤0.01% | 1694 |
|
|
2023
Q1 | – | Sell |
-1,600
| Closed | -$821K | – | 6004 |
|
|
2022
Q4 | $821K | Sell |
1,600
-7,100
| -82% | -$3.6M | ﹤0.01% | 4556 |
|
|
2022
Q3 | $3.95M | Sell |
8,700
-2,500
| -22% | -$1.2M | ﹤0.01% | 3347 |
|
|
2022
Q2 | $5.41M | Buy |
11,200
+3,700
| +49% | +$1.83M | ﹤0.01% | 3066 |
|
|
2022
Q1 | $3.68M | Sell |
7,500
-6,000
| -44% | -$2.74M | ﹤0.01% | 3636 |
|
|
2021
Q4 | $6.26M | Buy |
13,500
+2,700
| +25% | +$1.14M | ﹤0.01% | 3179 |
|
|
2021
Q3 | $4.03M | Buy |
10,800
+3,700
| +52% | +$1.41M | ﹤0.01% | 3537 |
|
|
2021
Q2 | $2.71M | Buy |
7,100
+4,000
| +129% | +$1.53M | ﹤0.01% | 3928 |
|
|
2021
Q1 | $1.11M | Sell |
3,100
-12,700
| -80% | -$4.08M | ﹤0.01% | 4515 |
|
|
2020
Q4 | $5.07M | Buy |
15,800
+6,500
| +70% | +$1.99M | ﹤0.01% | 2988 |
|
|
2020
Q3 | $2.5M | Sell |
9,300
-9,600
| -51% | -$2.58M | ﹤0.01% | 3418 |
|
|
2020
Q2 | $4.97M | Buy |
18,900
+2,700
| +17% | +$720K | ﹤0.01% | 2808 |
|
|
2020
Q1 | $3.68M | Buy |
+16,200
| New | +$4.41M | ﹤0.01% | 2876 |
|
|
2019
Q3 | – | Sell |
-17,500
| Closed | -$4.94M | – | 5213 |
|
|
2019
Q2 | $4.94M | Buy |
+17,500
| New | +$4.78M | ﹤0.01% | 2854 |
|
|
2018
Q2 | – | Sell |
-35,000
| Closed | -$7.69M | – | 5743 |
|
|
2018
Q1 | $7.69M | Buy |
35,000
+27,600
| +373% | +$6.48M | ﹤0.01% | 2568 |
|
|
2017
Q4 | $1.67M | Sell |
7,400
-33,900
| -82% | -$7.22M | ﹤0.01% | 3923 |
|
|
2017
Q3 | $7.84M | Sell |
41,300
-13,600
| -25% | -$2.59M | ﹤0.01% | 2773 |
|
|
2017
Q2 | $10.3M | Buy |
54,900
+38,400
| +233% | +$6.9M | ﹤0.01% | 2494 |
|
|
2017
Q1 | $2.73M | Buy |
16,500
+200
| +1% | +$31.8K | ﹤0.01% | 3454 |
|
|
2016
Q4 | $2.34M | Sell |
16,300
-39,700
| -71% | -$5.32M | ﹤0.01% | 3707 |
|
|
2016
Q3 | $7.02M | Buy |
56,000
+54,900
| +4,991% | +$7.09M | ﹤0.01% | 2745 |
|
|
2016
Q2 | $144K | Buy |
1,100
+1,000
| +1,000% | +$137K | ﹤0.01% | 5920 |
|
|
2016
Q1 | $14K | Sell |
100
-3,800
| -97% | -$508K | ﹤0.01% | 6828 |
|
|
2015
Q4 | $544K | Sell |
3,900
-1,700
| -30% | -$234K | ﹤0.01% | 4844 |
|
|
2015
Q3 | $784K | Sell |
5,600
-11,500
| -67% | -$1.73M | ﹤0.01% | 4709 |
|
|
2015
Q2 | $2.81M | Sell |
17,100
-7,400
| -30% | -$1.18M | ﹤0.01% | 3503 |
|
|
2015
Q1 | $3.78M | Sell |
24,500
-53,300
| -69% | -$7.59M | ﹤0.01% | 3167 |
|
|
2014
Q4 | $9.78M | Buy |
77,800
+6,100
| +9% | +$754K | ﹤0.01% | 2353 |
|
|
2014
Q3 | $8.58M | Sell |
71,700
-37,300
| -34% | -$4.28M | ﹤0.01% | 2489 |
|
|
2014
Q2 | $11.7M | Sell |
109,000
-12,500
| -10% | -$1.29M | ﹤0.01% | 2235 |
|
|
2014
Q1 | $12.1M | Sell |
121,500
-238,900
| -66% | -$21.6M | ﹤0.01% | 2195 |
|
|
2013
Q4 | $33.3M | Sell |
360,400
-5,800
| -2% | -$515K | 0.01% | 1362 |
|
|
2013
Q3 | $30.6M | Sell |
366,200
-59,600
| -14% | -$5.11M | 0.01% | 1308 |
|
|
2013
Q2 | $34.8M | Buy |
+425,800
| New | +$31.9M | 0.01% | 1135 |
|
Other funds holding ELV
VCM
VPM
Goldman Sachs's ELV Position: Q1 2026 in Review
Goldman Sachs reduced its Elevance Health (ELV) stake by 5.4% in Q1 2026, selling an estimated $27.7M and leaving 1,476,183 shares worth $432M. The position accounts for 0.05% of the portfolio, ranked #393.
Goldman Sachs first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.06B in Q4 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Goldman Sachs held 1,476,183 shares of Elevance Health worth $432M as of Q1 2026.
- Goldman Sachs sold 84,249 Elevance Health shares in Q1 2026, an estimated $27.7M.
- Elevance Health made up 0.05% of Goldman Sachs's portfolio in Q1 2026, its #393 holding.
- Goldman Sachs first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Elevance Health position peaked at $1.06B in Q4 2022.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.